Despite Rising Demand, Shoe Deodorizers Market Battles Negative Publicity

Published By : 10 Mar 2016 | Published By : QYRESEARCH

In recent years, shoe deodorizers have become an integral part of the personal care market, thanks mainly to the significant growth of the medicated foot market in the US.

Increasing Demand for Shoe Deodorizers Attributed to Surge in Diabetics 

The demand for shoe deodorizers stems mainly from patients suffering from hyperthyroidism and diabetes. An estimated 9.30 per cent of the people in the United States suffers from diabetes. The American Thyroid Association states that there are an estimated 20 million Americans that are suffering from one or the other type of thyroid. A rapid metabolic rate in hyperthyroidism results in excessive perspiration. Improper functioning of the autonomous nervous system caused increased sweating among diabetics over a period of time. This, in turn, results in the rising demand for shoe deodorizers. Sportspersons also feature in the consumer base for shoe deodorizers. 

Adverse Effects of Shoe Deodorizers Impeding Demand 

The requirement of shoe deodorizers to combat foot odor cannot be denied. However, the negative effects of the chemical components in shoe deodorizers have restricted a significant section of the patient population from using them. Some of the chemical compounds found in synthetic shoe deodorizers are known to cause certain allergies in the patients. Here are some of the chemicals used in synthetic shoe deodorizers:

  • Isobutene: Also used in a few aerosols, isobutene is a refrigerant that, when used in shoe deodorizers, is reported to cause exacerbated asthma and coughing. The US Food and Drug Administration, however, has ruled the chemical compound as safe. 
  • Tolnaftate: This chemical – used in a number of shoe deodorizer powders and sprays – is known to cause allergic skin reactions. For mothers coming in contact with the chemical in the first trimester of their pregnancy, the chemical compound may cause cardiac issues in the infants. 
  • Propyl Paraben and Propylene Glycol: Propyl paraben has been banned in the European Union since it is suspected to cause organ and skin damage. Propylene glycol, on the other hand, is suspected to cause immunotoxicity and toxicity.
Back To Top